DHL Supply Chain says it has agreed to acquire SDS Rx, expand healthcare reach
Summary
DHL Supply Chain has agreed to acquire SDS Rx, a last‑mile delivery specialist serving long‑term care and speciality pharmacies, radiopharmacies and health‑system networks. SDS Rx operates from more than 200 locations across the U.S., and the deal is intended to strengthen DHL’s same‑day and urgent delivery capabilities within its healthcare network. The acquisition is subject to regulatory approvals.
The move follows DHL’s earlier purchase of CryoPDP and sits within the company’s broader push to grow its healthcare logistics footprint. Mark Kunar, CEO of DHL Supply Chain North America, highlighted sector growth prospects and noted speciality pharmacy already accounts for roughly 50 per cent of U.S. prescription drug spending, with patient volumes rising in recent years.
Key Points
- DHL Supply Chain has agreed to acquire SDS Rx to expand last‑mile healthcare delivery services in the U.S.
- SDS Rx operates from 200+ U.S. locations, bringing footprint and operational capacity to DHL’s network.
- The acquisition aims to improve DHL’s same‑day and urgent delivery options for healthcare customers.
- Closing of the deal remains subject to regulatory approvals.
- Transaction follows DHL’s prior healthcare-focused acquisitions (for example, CryoPDP) and aligns with its wider investment in healthcare logistics.
- Market context: the life sciences and healthcare sector is forecast to grow strongly through 2030, and speciality pharmacy represents a large and growing share of prescription spending.
Context and relevance
This deal is part of a clear consolidation trend in healthcare logistics where large 3PLs are buying specialised last‑mile providers to win urgent, temperature‑sensitive and speciality pharmacy business. For logistics managers, pharmacy chains and health systems, the acquisition could mean broader same‑day coverage and tighter integration of urgent delivery services under a major global provider.
For investors and competitors, it signals DHL’s continued prioritisation of healthcare as a growth vertical and suggests further M&A activity may follow as 3PLs race to secure speciality and time‑critical capabilities.
Author style
Punchy — this is a noticeable strategic step for DHL in healthcare logistics. If you’re tracking 3PL moves or last‑mile healthcare capability, the details matter: footprint, same‑day capacity and regulatory timing will shape how quickly DHL can realise the benefits.
Why should I read this?
Short and blunt: if you work in healthcare logistics, pharmacy distribution or you’re keeping an eye on 3PL consolidation, this matters. It affects coverage for same‑day and urgent deliveries, could change contracting options, and is a sign DHL is doubling down on healthcare — so it’s worth a quick read to see how it might affect your supply chain choices.